作者
Amber Salter, Robert J Fox, Scott D Newsome, June Halper, David KB Li, Pamela Kanellis, Kathleen Costello, Bruce Bebo, Kottil Rammohan, Gary R Cutter, Anne H Cross
发表日期
2021/6/1
期刊
JAMA neurology
卷号
78
期号
6
页码范围
699-708
出版商
American Medical Association
简介
Importance
Emergence of SARS-CoV-2 causing COVID-19 prompted the need to gather information on clinical outcomes and risk factors associated with morbidity and mortality in patients with multiple sclerosis (MS) and concomitant SARS-CoV-2 infections.
Objective
To examine outcomes and risk factors associated with COVID-19 clinical severity in a large, diverse cohort of North American patients with MS.
Design, Setting, and Participants
This analysis used deidentified, cross-sectional data on patients with MS and SARS-CoV-2 infection reported by health care professionals in North American academic and community practices between April 1, 2020, and December 12, 2020, in the COVID-19 Infections in MS Registry. Health care professionals were asked to report patients after a minimum of 7 days from initial symptom onset and after sufficient time had passed to observe the COVID-19 disease course through …
学术搜索中的文章
A Salter, RJ Fox, SD Newsome, J Halper, DKB Li… - JAMA neurology, 2021